News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication May 10, 2020 Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 10, 2020 Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 10, 2020 Evaluating the Optimum Number of Biopsies to Assess Histological Inflammation in Ulcerative Colitis: A Retrospective Cohort Study Brian Feagan, Guangyong Zou, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 10, 2020 Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews Brian Feagan Read Now
Publication May 10, 2020 Response to Placebo, Measured by Endoscopic Evaluation of Crohn’s Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials Brian Feagan, Guangyong Zou, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 10, 2020 Development of the Symptoms and Impacts Questionnaire for Crohn’s Disease and Ulcerative Colitis Brian Feagan, Christopher Ma, Vipul Jairath Read Now
